What changed
$ISRG — AVOID 📊
Intuitive Surgical, Inc.
🎯 Q1 FY26 | Rev $3B | EPS $2.50 vs $2.11 🟢 | Margin 30.9%
💡 Consensus expects continued high procedure growth and margin expansion, as reflected in the 50.3x P/E. Our variant view is that the market underestimates the potential for multiple compression if procedure growth decelerates toward more normal levels or if competitive entrants gain traction.
📉 Reward/Risk: 0.89:1
🏢 Business Quality: 9/10 - Wide moat from installed base, razor/blade model with high switching costs, and innovative pipeline (da Vinci 5). Strong margins and cash generation, but capital-intensive and faces regulatory/reimbursement headwinds.
📊 Valuation: rich - Current P/E 50.3x is near the high end of its historical range (49.7x-57.2x) and a huge premium to healthcare peers (9.9x-14.4x-24.4x).
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/ISRG0612
Also in play: $MOH $DHR $TMO $BDX $SYK $NVDA